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ABSTRACT
The insertion of magnesium into protoporphyrin initiates the biosynthesis of chlorophyll, the pigment that underpins photo-
synthesis. This reaction, catalysed by the magnesium chelatase complex, couples ATP hydrolysis by a ChlID motor complex
to chelation within the ChlH subunit. We probed the structure and catalytic function of ChlH using a combination of X-ray
crystallography, computational modelling, mutagenesis and enzymology. Two linked domains of ChlH in an initially open
conformation of ChlH bind protoporphyrin IX and rearrangement of several loops envelops this substrate forming an active site
cavity. This induced fit brings an essential glutamate (E660), proposed to be the key catalytic residue for magnesium insertion,
into proximity with the porphyrin. A buried solvent channel adjacent to E660 connects the exterior bulk solvent to the active site,
forming a possible conduit for delivery of magnesium or abstraction of protons.
The central metal ions in the cyclic tetrapyrrole-derived cofactors, magnesium in chlorophyll, cobalt in cobalamin, iron in
heme, and nickel in F430, are collectively critical for most living systems. These tetrapyrroles underpin photosynthesis, vitamin
B12 biosynthesis, respiration and methanogenesis1. Despite their apparent simplicity, the insertion of each metal ion into its
cognate macrocyclic ring requires surprisingly complex and poorly understood enzymes. These metal ion chelatases can also
play a regulatory role in directing and controlling flux down various branches of tetrapyrrole metabolism. A comparatively
good structural and mechanistic understanding exists for the relatively simple Class II chelatases2–6, but our knowledge of the
complex, multisubunit, Class I chelatases, typified here by magnesium chelatase, is more limited.
Much of the mechanistic work on this class of chelatases has focused on the reasonably tractable magnesium chelatases
(MgCH; E.C.6.6.1.1) from bacteriochlorophyll and chlorophyll producing organisms. MgCH initiates the biosynthetic pathways
for these pigments by inserting Mg2+ into the protoporphyrin macrocycle (Fig. E1) . MgCHs require at least three subunits;
chlorophyll producing organisms have ChlI (~ 35 kDa), ChlD (~ 75 kDa) and ChlH (~150 kDa), and the closely related proteins
from bacteriochlorophyll producing organisms are BchI, BchD, and BchH7, 8. In cyanobacteria and higher plants a fourth
regulatory subunit, Gun4, is required for full protein activity9–11.
The genes for MgCH were originally identified and recombinant protein expression systems were developed some time
ago7, 12, and extensive kinetic characterization of the MgCH has identified the roles of the subunits13–18. The current mechanistic
and structural data suggest a model for the MgCH mechanism where the two AAA+ subunits form the ChlID complex16, 19.
This complex transiently interacts with the body region of the ChlH protein via the C-terminal integrin domain of ChlD20, then
hydrolyses ATP, which drives a conformational change in the ChlH-porphyrin complex, promoting insertion of the Mg2+ ion
into the protoporphyrin IX (PIX) ring21. This sequence of events accounts for the kinetic data, but a complete model requires
structural information for all three proteins, in particular the porphyrin binding subunit ChlH, where insertion of Mg2+ takes
place. SAXS and electron microscopy of negatively stained ChlH, provided low resolution views of the ChlH protein, both free
and bound to porphyrin22, and the recently published crystallographic structure of apo-ChlH from Synechocystis at 2.5 Å23
represented a significant advance in structural studies of this subunit. Based on the shape of the protein, together these studies
show that ChlH consists of three major domains, described as the head, neck and body of the protein17, 22. From the crystal
structure, the body is described as ‘cage-like’, with several sub-domains surrounding an internal cavity postulated to be the
substrate binding site23, consistent with the demonstration that a mutant of ChlH lacking the head and neck regions can still
catalyse metal ion insertion17.
Given the lack of detailed structural or mechanistic evidence for the location of the porphyrin binding site or key catalytic
residues, we have used a series of approaches to characterise the putative active site of magnesium chelatase. Here we present
a high-resolution (1.6 Å) crystal structure of a 45 kDa truncated construct of Thermosynechococcus elongatus ChlH, a 2.5
Å resolution structure of full-length WT Synechocystis ChlH and the structures of several catalytically altered mutants. We
identified a number of residues likely to be involved in substrate binding and catalysis, which were tested by site directed
mutagenesis, kinetic studies and crystallography. This combination of approaches has allowed us to make a detailed proposal
for the magnesium insertion step in chlorophyll biosynthesis.
Results
An inactive, truncated form of ChlH from Thermosynechococcus elongatus (T_ChlH_926) (residues P926-E1326) was designed
based on a structural study of a corresponding fragment of the cobalt chelatase CobN subunit (Prof. M Warren, University
of Kent, personal communication). A seleno-methionine derivative was used to experimentally derive phases and build a
preliminary model, which was subsequently used to determine a 1.6 Å resolution structure of the native protein (Table E1).
T_ChlH_926 is largely alpha-helical, with a small seven-stranded beta-sheet at its core (Fig. 1 a) that underlies a prominent
surface groove (Fig. 1 b). T_ChlH_926 has 78% sequence identity with the corresponding region of full-length ChlH from
Synechocystis sp. PCC 6803 and comparison with a previously published structure of this protein (PDB:4ZHJ)23 shows that the
surface groove observed in the T_ChlH_926 structure represents a portion of the putative active site cavity. After refinement of
the polypeptide structure, inspection of the difference density map revealed two peaks within the surface groove that could
not be accounted for by the protein or by water molecules. One of the peaks corresponded to a 6-coordinate metal which,
based on ligand distances and size of the peak in comparison to the surrounding protein, was modelled as a potassium ion (Fig.
1 d). The ligands surrounding this site include three water molecules, the sidechain of K200 and the mainchain amides of
G111 and A174 (metal-ligand distances 2.91 Å, 3.05 Å, 3.32 Å, 3.53 Å, 3.15 Å and 3.22 Å, respectively). In the structure of a
similarly truncated form of ChlH from A. thaliana (PDB: 5EWU)24 (72% sequence identity to T_ChlH_926 and RMSD Cα:
0.53 Å) (Fig. 1 c-d) this same site has been modelled to be occupied by a magnesium ion. The second difference peak sits
in a slight depression between the sidechains of W56, T58, S110 and V112, indicating the binding of a small molecule that
either exogenously co-purified with the protein or that originated from the crystallisation conditions. Intriguingly, a molecule
of benzoate occupies the same position in the A. thaliana ChlH structure, with the carboxyl group of the benzoate forming
hydrogen bonds with the mainchain amide of G1034 and T1035, and sidechains of T1035 and S1087 (equivalent to G57, T58
and S110, respectively, in T_ChlH_926), indicating the location of a putative carboxyl binding site (Fig. 1 d). Despite the
high-resolution of the T_ChlH_926 structure, it is not possible to identify the bound ligand, which may be partially disordered.
Nevertheless, the conservation of both the architecture of this region and the surrounding residues (Fig. 1 d), suggests that this
site may be important for substrate binding. We therefore hypothesised that this could be the binding site of one of the two
pendant propionate groups of the ChlH substrate, PIX, assigning it as site 1.
To get a better overview of the structure of the putative active site of ChlH and identify the second propionate binding
site, we determined a 2.5 Å structure of full-length ChlH from Synechocystis sp. PCC 6803 (Syn_ChlH) (Table E1) by
molecular replacement using a previously published 2.5 Å model of the enzyme (PDB:4ZHJ)23. Model building was aided
by our high-resolution structure of T_ChlH_926, which represents 30% of the scattering matter in the crystal. The structure
of Syn_ChlH is best described as comprising four domains (Fig. 2 a). The head (M1-P215) and neck (P232-D337) domains,
connected by a long loop that is not visible in the structure, are packed against the body domain, which is formed of two
sub-domains; Body I (A338-P942) and Body II (T950-V1330). The two halves of the body comprise roughly equally sized
portions connected by a loop (A942-T950) (Fig. 2 b). Body II is the part of the full-length structure represented by the
T_ChlH_926 truncate, whilst Body I forms a C-shape structure that embraces Body II (Supplementary Fig. S1 a), forming the
compact cage-like structure described previously23. The active site cavity lies at the interface between the two body domains
and is enclosed on all sides by protein, with a loop (Loop 1) (G466-L474) from Body I blocking access to the external solvent at
the top of the cavity (Fig. 2 c and Fig. 3 b). Loop 1 and a number of surrounding loops, also from Body I (Loop 2: F618-K630
and Loop 3: Q575-D583), have varying degrees of order across the multiple copies of Syn_ChlH represented in our set of WT
and mutant structures, suggesting that they are flexible.
There are two prominent electron density features (5 and 8 σ ) sat deep within the active site cavity that could not be
accounted for by the protein or by solvent structure, indicating the binding sites of unknown ligands (Fig. 2 b-c). The first
corresponds to site 1 from the T_ChlH_926 structure, analogous to a site for hydrogenobyrinic a,c-diamide (HBAD) binding in
a truncated CobN subunit (Prof. M Warren, University of Kent, personal communication). The second electron density feature
(site 2), around 11 Å away, corresponds to the location of the bound potassium ion in the T_ChlH_926 structure. Site 2 is
surrounded by a cluster of residues including S1103, K1129, D1177A and S1178A (Fig. 2 c-d and Fig. 3 c). Each electron
density feature sits above the N-terminal end of a short helix and has a pair of exposed main chain amides directly beneath it
(site 1; T987 and G986, site 2; V1041 and G1040), which are well positioned hydrogen bond donors to interact with the two
propionate groups of the substrate (Fig. 2 d). The inside surface of the active site cavity around this region is largely positively
charged, higher up it is neutral and at the top of the cavity next to Loop 1 it is more negatively charged, creating a charge gradient




Figure 1. a, A cartoon representation of the Thermosynechoccus elongatus ChlH truncate, T_ChlH_926, coloured from the
N-terminus (blue) to the C-terminus (red). A bound potassium ion is shown as a purple sphere. b, A surface representation
(blue) of T_ChlH_926 in the same view as a. The black arrow indicates the location of the surface groove containing the
potassium ion (white asterisk). c, A superposition of T_ChlH_926 (blue) with the structure of a similar truncate of ChlH from
A. thaliana (beige), showing their conserved fold. The potassium ion bound to T_ChlH_926 and the benzoate molecule from
the A. thaliana ChlH structure are shown as a purple sphere and as magenta spheres, respectively, indicating the conserved
position of the surface groove. Helices are represented as cylinders. d, A detailed view of the binding groove of T_ChlH_926
(blue) superimposed on that of A. thaliana ChlH (beige) showing the conservation of amino acids in this region (numbering
taken from the T_ChlH_926 structure) and the interactions that they make with the ligands in each structure. Also shown is a
section of the Fo-Fc difference map from the T_ChlH_926 structure (green mesh, contoured at 3 σ ) indicating the binding site
of an unidentified ligand, the position of which corresponds to the benzoate in the A. thaliana ChlH structure, suggesting a
conserved carboxyl binding site. We have termed this putative propionate binding site, site 1.
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ligands, so to rule out an endogenous source we carried out gentle denaturation, refolding and HPLC of the enzyme prior to
crystallisation. The features persisted (data not shown), leading us to believe that they must originate from the crystallisation
conditions. Small carboxylic acids fit within the electron density features (butanoic or propanoic acid) but neither are present in
the crystallisation, so we assume that these electron density features represent partially ordered molecules of citrate. Citrate
inhibits magnesium chelatase activity (Ki,app ≈ 80 mM Supplementary Fig. S2) and although its binding is relatively weak, at
high concentration (≈ 1 M citrate in the crystallisation experiment) it is feasible that Syn_ChlH-citrate complexes would form.
We attempted to crystallise Syn_ChlH without citrate and with a number of different substrate analogues, both by soaks and
co-crystallisation, but were unsuccessful. We believe that a "closed" form of Syn_ChlH crystallises, which is similar to that
previously observed in a low-resolution (≈ 30 Å) electron microscopy maps22 and that perhaps the crystallisation is driven by
citrate binding. The relative positions of sites 1 and 2 and the presence of a pair of main chain amides underlying each site (Fig.
2 d) suggests that these could be the binding sites for the two propionate groups of PIX.
Computational modelling of substrate binding by ChlH
In order to determine if sites 1 and 2 were accessible by substrate, we carried out modelling studies. It quickly became apparent
from manual docking that with the two propionate groups docked in sites 1 and 2, the position of Loop 1 makes the active
site cavity too small to accommodate PIX (Fig. 3 a-b). However, we predict that Loop 1 is flexible (Supplementary Fig. S3),
therefore its conformation in our structure may not be representative of its conformation in the presence of substrate. From the
relative positions of Loop 1 and the docked substrate, we hypothesise that Loop 1 interacts directly with the substrate via its A-
and B-ring substituents, which could facilitate closure of the active site by induced fit. Given this hypothesis, we prepared the
structure for computational modelling (AutoDock Vina25) by removing residues T470-Y473 from Loop 1, as well as water
molecules, and adding polar hydrogen atoms.
The top hit from the computational modelling (Fig. 3 a-c) places the C-ring propionate group of PIX in site 1 and the
D-ring propionate group into site 2. However, due to the symmetry of the molecule across the C- and D-rings, PIX can be
also be modelled the other way round with the D-ring propionate in site 1 and C-ring propionate in site 2. This is because the
atomic coordinates for Loop 1 were removed from the protein structure prior to the modelling, therefore the asymmetrical
substituent groups on the A- and B-rings have nothing to pack against and thus, the orientation cannot be defined by the model.
Nevertheless, the modelling supports our visual analysis, confirming that we have two propionate binding sites in the base of
the Syn_ChlH binding pocket. The hydrogen bonding network around each of the propionate groups is not clearly defined by
the computational modelling, which has its limitations, but the position of the propionate groups suggests that they interact with
the protein via the pair of main chain amides that underlie each site (site 1; T987 and G986, site 2; V1041 and G1040) as well
as some of the surrounding side chains. Thus, we defined a set of residues around each of the putative binding sites to mutate
(Site 1: S1039, V1041, T987 and D988, Site 2: S1103, K1129, D1177 and S1178, Table E2, Supplementary Table S1 and Fig.
3 e-f). All these residues are positioned on the Body II domain of Syn_ChlH and are conserved in ChlH from cyanobacteria,
algae and higher plants, but there is less conservation with the related cobalt chelatase HBAD binding subunit, CobN (Fig. 3 d,
Supplementary Fig. S5). Prior to any structural information, we also identified two other potential carboxyl binding residues
(R667 and K991) that could be involved with substrate binding based on sequence conservation with CobN (Table E2). In order
to determine if any of these residues were involved with substrate binding or catalysis we subjected the mutant enzymes to
kinetic assays.
Activity and substrate binding assays in Syn_ChlH mutants
Interpreting the functional role of individual residues using steady-state kinetic measurements is challenging because of the
complexity of the magnesium chelatase reaction mechanism. Three subunits (H, I and D) form the active complex and multiple
enzymatic steps occur, so it is clearly inappropriate to assume that individual steady-state parameters reflect clearly defined
reaction steps. They do however provide a clear overview of the effect of structural change. It is also possible to directly
measure porphyrin binding affinity to ChlH26 and in the analysis of our mutant enzymes we have determined binding constants
(Kd) for DIX. In the analysis of the mutant enzymes we have therefore used a combination of porphyrin binding, measuring
disruption of the active site, and steady-state kinetics to probe the overall ability of the mutant enzymes to catalyse the chelation
reaction. In the analysis of steady-state kinetics, values for kcat are calculated based on the concentration of ChlH.
Site 1 mutations
All four site 1 mutants (T987A, D988A, S1039A and V1041A) have impaired binding to substrate, with a higher KdDIX (2.3-6.3
µM) than WT (≈ 0.65 µM) (Table E2 and Supplementary Fig. S4), consistent with our structural proposal. They also have
lower turnover (kcat) and lower catalytic efficiency (kcat/KM), compared to WT (Table E2). D988 sits underneath T987 and
G986 (site 1 mainchain amides, see Fig. 2 d) and is involved in a network of water-mediated hydrogen bonds involving H1174.
The D988 sidechain is fully hydrogen bonded in our structure (3 water molecules and S669-OH), therefore it may be structurally




Figure 2. a, The three-dimensional fold of full-length Syn_ChlH represented as a cartoon. The head and neck domains are
coloured green and yellow, respectively, with the body domain represented as two sub-domains, coloured according to the
N-terminal portion (Body I; teal), which forms a C-shaped domain which cradles the N-terminal portion (Body II; pale blue).
Body II is equivalent to the T_ChlH_926 structure (see Supplementary Fig. S1). The position of the active site (AS) is
indicated by a grey circle; Loop 1 (red) and a potential hinge region (orange) are highlighted. b, The two sub-domains of the
body are connected by a surface-exposed, hinge-like loop (orange) (A942-T950). c, Details of the active site cavity showing the
difference density features (grey volumes) that indicate the binding of small molecules in sites 1 and 2. The potassium binding
site from the T_ChlH_926 structure (purple sphere) that sits adjacent to S2 is overlaid and Loop 1 is shown in red. The
sidechains of E660 and H1174 are also shown. d, Sites 1 and 2 are positioned at the N-terminal ends of two short helices, with
a pair of mainchain amides sat directly underneath (small white spheres) (1=T987, 2=G986, 3=V1041, 4=G1040). These are














































































































Figure 3. A model of PIX binding in Syn_ChlH. a, PIX (green sticks) sits within the central cavity of Syn_ChlH (partially
transparent grey surface) with its two propionate groups docked in site 1 (S1) and 2 (S2). E660 sits on one side of the ring on
the Body I domain (teal) and H1174 sits opposite it on the Body II domain (pale blue). The position of Loop 1 (red) is not
compatible with the modelled position of the substrate, suggesting that its conformation would have to be different in a
substrate-bound form of the enzyme. b, A more detailed view of Loop 1 (red) (shown as sticks and with residues labelled).
Body domain colours are the same. c, A top-down view of the active site with PIX (green) docked. Potential substrate binding
residues around site 1 (yellow), site 2 (pink) and from sequence alignments with CobN (cyan) are shown as sticks on a ribbon
backbone. E660 and H1174 are also shown. Sites 1 and 2 are represented by the difference density features observed in the
full-length structure (grey partially transparent surface). Body domain colours are the same. d, Sequence alignment and
secondary structure representations of the sequence highlighting the level of conservation amongst ChlH proteins and CobN for
these core residues. Sequence alignment is coloured using the Clustal X colour scheme. TH. H, Thermosynechococcus
elongatus; AT. H, Arabidopsis thaliana; OS. H, Oryza sativa subsp. japonica; ChlH, Synechocystis sp. 6803; SC. H,
Synechococcus sp. (strain WH8102); PM. H, Prochlorococcus marinus (strain MIT 9301); TS. H, Thermosynechococcus sp.
NK55a; CobN, Brucella melitensis. Numbering represents Syn_ChlH residue numbers. e, Steady state magnesium chelatase
assays with respect to DIX for site mutants. Assays contained 0.1 µM ChlD, 0.2 µM ChlI, 0.4 µM WT or mutant ChlH in 50
mM MOPS/KOH, 0.3 M glycerol, 1 mM DTT, 10 mM free Mg2+, 5 mm MgATP2-, pH 7.7. The lines are theoretical, with
steady state rates described by fitting to the equations as listed in Table E2, along with fit coefficients. f, as for e, but for Site 2
mutants. The D1177A mutant (cyan) shows fits to both the Michaelis-Menten model (solid line) and substrate inhibition model
(dashed line). In panels e and f, each data point is an independent experiment.
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change the enzyme kinetics from a standard Michaelis-Menten rectangular hyperbola to a sigmoid, that can be described by the
Hill equation with n of 1.7-1.9, which could suggest cooperativity. In our model, these three residues are predicted to hydrogen
bond with the C-ring propionate of PIX, either by mainchain or sidechain interactions. The positive cooperativity induced by
these mutations are difficult to rationalise, but could explained by local structural changes around site 1 or by longer-range
effects27. Overall, the subtle increase in Kd we observe for these mutants reflects the contribution of the WT sidechains to
substrate binding in addition to the pair of mainchain amides that underlie site 1, agreeing with our model.
Site 2 mutations
We probed site 2 by making S1103A, K1129A, D1177A and S1178A mutations. As well as the mainchain amides from V1041
and G1040 that underlie site 2 (Fig. 2 d), the computational modelling suggests that the mainchain amide from S1103 could
also act as a hydrogen bond donor to the D-ring propionate of PIX. Mutating S1103 to alanine does perturb binding and turnover
somewhat, but the effects are far more dramatic with the K1129A mutant, which has ca. 10% of the catalytic efficiency of WT,
and an order of magnitude weaker binding to DIX. In our structure, D1177 and S1178 sit in a constellation around K1129, with
their sidechains pointing towards the molecule of docked PIX. The space between the sidechains forms a small cavity adjacent
to site 2. The N-zeta atom of the amino group of K1129 is ≈ 4.5 Å away from the nearest oxygen atom of the D-ring propionate
group and a very subtle rearrangement could bring it within hydrogen bonding distance of the substrate. The big increase
in Kd that we observe for the K1129A mutant is consistent with a direct interaction with the propionate group in site 2. For
D1177 and S1178 a greater degree of movement would be required, so perhaps they facilitate water mediated interactions with
the substrate or interact with the substrate in a different conformation of Syn_ChlH. Both the D1177A and S1178A mutants
retain tight binding of DIX (Table E2). Intriguingly, mutating D1177 to an alanine displays behaviour reminiscent of substrate
inhibition, with a Ki value of 37 µM and a KM value consistent with tight binding to DIX during catalysis. This substrate
inhibition behaviour has been previously observed with the Themosynechoccus elongatus enzyme28. The D1177A mutation
may increase non-productive binding of substrate to ChlH leading to the observed substrate inhibition29. D1177A still has quite
a high turnover number, and as such is actually more catalytically efficient than WT. The S1178A mutant also has a lower
KM and Kd (almost three times tighter binding to substrate than WT), but due to kcat being significantly lower than WT, the
overall effect is for a less catalytically efficient enzyme. Overall, the results of these mutational and kinetic analyses support the
computational modelling and our hypothesis that this region is responsible for binding the D-ring substituents of PIX.
Mutation of conserved positively charged residues
Prior to the determination of the full-length structure of Syn_ChlH, we used the structure of T_ChlH_926 along with sequence
conservation to identify R667 and K991, conserved positively charged residues that could be near to the active site. Mutation of
either residue to alanine in Syn_ChlH reduces the binding affinity of substrate, (Kd for DIX 9.26 µM and 4.53 µM, respectively,
compared to WT, ≈ 0.65 µM) (Table E2 and Supplementary Fig. S4), but whilst the K991A mutant still retains some enzyme
activity, the R667A mutant is completely inactive; the same is true for R667K and R667E mutants. Analysis of the Syn_ChlH
structure shows that R667 is surface exposed and forms an intramolecular hydrogen bond to Y1102 that bridges across the
domain interface between the two halves of the body. From its position in the structure it is unlikely to interact with the
substrate directly, but as mutation of this residue abolishes activity (Table E2) it is clearly critical, perhaps serving as a latch
that stabilises the closed form of the enzyme. K991 is an important structural residue, with its sidechain amino group making
three hydrogen bonds to a water molecule, sidechain of D1163 and the mainchain carbonyl on N656, respectively. It serves as a
linchpin in the hydrogen bond network on one side of the active site cavity, and therefore plays a structural role. Both residues
are important for enzyme activity in Syn_ChlH, but neither seems to be involved with substrate binding directly.
Residues critical for catalysis in the Syn_ChlH active site
Having shown that the mutational studies around sites 1 and 2 are consistent with our computational model of substrate binding,
we sought to identify nearby residues that could be involved with catalysis. With the two propionate groups of the modelled
substrate docked at the base of the active site, the porphyrin ring is sandwiched closely between the two walls of the cavity. On
one side of the cavity, H1174 sits adjacent to the center of the porphyrin ring and on the opposite wall, projecting toward the
other face of the porphyrin ring, is a strictly conserved glutamate residue (E660) (see sequence alignments in Fig. 3). This
generates a Glu-His pair that form an axis (Glu-O to His-N = 6 Å) near to the predicted position of the magnesium binding site
of the porphyrin ring (Fig. 2 c and Fig. 3 a).
An axial histidine would be well placed to either act as a base that abstracts protons from the porphyrin substrate and/or
interact with the central Mg2+ ion of the product. Histidines have a catalytic role in a number of class 2 chelatases, including
CbiK (an anaerobic cobalt chelatase from Salmonella typhimurium;30 and Bacillus subtilis, human and Saccharomyces cerevisiae
protoporphyrin IX ferrochelatases;31–33). H1174 is conserved across the entire magnesium chelatase family (Supplementary
Fig. S8), but not in the analogous subunit in the cobalt chelatase, CobN, where it is replaced by an aspartate, perhaps reflecting
the difference in metal ion specificity. In ferrochelatase, the equivalent axial histidine (H263, human protein residue numbering)
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is hypothesised to assist in proton abstraction from the porphyrin and mutation of this residue leads to severely impaired or
inactive enzyme34, 35. In Syn_ChlH mutation of H1174 to a valine showed no decrease in chelatase activity (Fig. E2 a & b,
Table E3 and Supplementary Table S1), nor was the Kd for DIX binding significantly altered (Kd = 0.77 µM compared with
0.65 µM for WT, Supplementary Fig. S6), demonstrating that it is not critical for binding or catalysis. Density functional
theory calculations for Mg2+ insertion into porphyrin show a steep increase in the energetic challenge of deprotonation of the
porphyrin ring by a water molecule as opposed to a histidine base36. We conclude, therefore, that H1174 is not catalytic, but it
is in a convenient position to interact with the central magnesium. As histidine is a common ligand binding moiety in many
chlorophyll binding proteins, perhaps it provides a stabilising interaction to anchor the Mg2+ ion until MgPIX is released, but
more evidence is required to confirm this.
The position of E660 on the other side of the porphyrin ring suggests that it could also interact with the central magnesium
ion during catalysis. Accordingly, we made several mutations, including E660R, E660H, E660D and E660Q (Supplementary
Fig. S8). Assays showed (Fig. E2 c & d, Supplementary Figs. S6 & S8, Table E3) that only by retaining a carboxyl group at
position 660, via an aspartate residue, could any activity be retained (5 % compared to WT). We also determined a structure of
E660D Syn_ChlH, showing that it is essentially the same as WT (RMSD Cα: 0.153 Å) (Table E1). The E660D mutant was
able to bind DIX with a Kd well within the range of other active mutants of ChlH, (E660D Kd = 3.05 µM, WT Kd = 0.63 µM),
so the active site is still folded and able to bind DIX, but the kcat value for the E660D mutant is dramatically reduced compared
to WT (Table E3). The E660D mutation produces a large increase in KM with respect to DIX, which is likely due to a decrease
in catalytic proficiency of the enzyme, clearly demonstrated by the large decreases in the value for kcat/KM (or kcat / S0.5 for
Mg2+). This shows that the carboxyl group of E660 is essential for catalysis in Syn_ChlH and its location, adjacent to the
center of the porphyrin ring, suggests that E660 plays a crucial role in inserting the Mg2+ ion into PIX.
To further demonstrate that E660 sits adjacent to the substrate, we mutated it to a tryptophan (E660W) and carried out
Förster Resonance Energy Transfer (FRET) assays, monitoring emission from DIX following excitation of tryptophan at
280 nm15. The E660W protein still binds DIX and as with the majority of the E660 mutants is inactive (Kd = 0.30 µM,
Supplementary Fig. S7). The crystal structure of ChlH_E660W (Table E1) shows that the fold is very similar to WT (RMSD
Cα : 0.30 Å). All of the putative substrate binding residues within the Body II domain of the enzyme are in conserved positions
(Fig. 5) and the tryptophan is tolerated by packing the face of the indole ring against the wall of the active site, with some local
rearrangement of adjacent loops (Loop 1-3) (see Fig. 5 c-d). The DIX fluorescence emission from the E660W mutant was
47% greater than from the WT protein, while a control mutation, E263W, where the tryptophan is ca. 50 Å from the proposed
porphyrin binding site, only showed a 7% increase in fluorescence (Fig. E3). Thus, we conclude that the substrate binds in
close proximity to W660 providing direct evidence that the central cavity is the binding site of PIX. Finally, Trp fluorescence
quenching experiments have suggested that Syn_ChlH may bind substrate in a distorted non-planar conformation26 and several
crystal structures of unrelated proteins, including PDB:4UC1 and PDB:5DUO (both Rhodobacter sphaeroides translocator
proteins) have non-planar porphyrins bound. Visual analysis of the active site cavity of Syn_ChlH shows that there is a lateral
bend, such that a bowed substrate would bind with the convex face of the porphyrin ring pointing towards E660, presenting the
four central nitrogen atoms of the porphyrin to the carboxyl side chain. This suggests that bending of the substrate within the
Syn_ChlH cavity might facilitate metal insertion, although more work is required to confirm this.
Insights into magnesium ion binding in ChlH
Chelation of magnesium by PIX requires a delivery mechanism to supply magnesium ions to the active site. This could either
be achieved by direct uptake of magnesium by ChlH or an, as yet unknown, direct delivery mechanism from ChlD or ChlI.
None of our Syn_ChlH structures have sufficient resolution to observe bound magnesium ions, a problem compounded by the
complexity of the difference map features in the active site arising from binding of citrate. However, examination of the section
of difference map adjacent to E660 reveals an intriguing chain of four buried electron density features sitting behind Loop 2
(F618-K630 ordered, disordered to P640) indicating a solvent-filled channel that leads from the surface of the protein to the
active site. Although the surrounding residues are tightly packed against the buried solvent, a degree of local motion would
make parts of this channel wide enough to accommodate a partially hydrated magnesium ion, notwithstanding the fact that this
region of the enzyme may undergo substantial conformational change when in complex with ChlD and ChlI.
Dummy atoms were modelled into the centre of each electron density feature to aid interpretation, but these are not present
in the deposited coordinates. The closest feature to E660 (feature 1) (Fig. 4 a-b) sits in a largely hydrophobic environment,
with only the C-O of E660 and the next feature (feature 2) sat within hydrogen bonding distance. Feature 2 is surrounded by
another three interacting groups, including the C-O of G622, -OE2 of E625 (both 2.7 Å away) and -OH of Y653, which is 2.2
Å away. This is too close for a water molecule and could be consistent with an O-Mg distance, notwithstanding the error in the
map due to the limited resolution. The -OE1 of E652 points away from the solvent filled channel, hydrogen bonding to the -OH
group of Y651. The -OE1 group of E625 also sits at the interface with bulk solvent, via a second empty channel that penetrates
deep inside the body of Syn_ChlH, and is within hydrogen bonding distance to feature 3, along with the main chain amide of
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H621. Feature 4 sits 5 Å away from feature 3, also at the interface with bulk solvent. Two groups are within hydrogen bonding
distance of feature 4, the C-O of T457 and main chain amide of F618.
Y651, Y653 and E625 are strictly conserved across the ChlH family suggesting they are important (Fig. 4 c, Supplementary
Fig. S5), thus to explore a potential role in metal binding, we made a series of mutations at the Y653 and E625 positions.
Mutation of Y653 to a threonine still allows for substrate binding with a similar Kd to WT, but only reduces kcat by ~40 %,
suggesting that Y653 is not essential for supplying magnesium to the active site. To explore a possible role for E625 in metal
binding we made E625D, E625H, E625K and E625Q mutants, all of which produced normally folded protein (Supplementary
Fig. S9) and bound substrate with a Kd similar to WT, but with abolished chelatase activity. Due to this complete loss of activity
it is difficult to be certain if E625 has a role in metal delivery, but from the conformation of the protein in our structure we can
rule out a direct interaction with the substrate, since E625 is ~8 Å away from E660 (closest O to O distance) and points away
from the active site. Given that the E625D mutant is also completely inactive, this suggests that there is also no tolerance for
altering the position of the carboxyl group. We managed to obtain a crystal structure of the E625K mutant to 2.8 Å resolution
(Table E1). Most of the structure is identical to the WT enzyme, including all of the substrate binding residues surrounding
the propionate binding sites on the Body II domain and the position of the E660/H1174 pair. However, the K625 sidechain is
pulled into the active site, altering the conformation of Loop 2 (F618-P640, disordered in the structure after residue 267), and
obliterating the buried solvent channel. The conformational change of Loop 2 also destabilises the packing arrangement around
Loop 1, the path of which is difficult to interpret from the electron density map. These conformational changes alter the shape
of the active site cavity, creating more volume adjacent to E660. Interestingly, both the E625K and E660W structures show that
a large degree of conformational change can be tolerated by the loops that overlie this buried channel (Loops 1-3), without
causing much change in the positions of the substrate binding residues on the other side of the binding pocket. Consequently,
they still bind substrate as well as WT.
Acidic residues adjacent to E660 would be likely candidates to be involved with vectoral delivery of magnesium to the
active site, thus the position of E625 and its access to bulk solvent via a buried channel is consistent with a potential role in
magnesium delivery. However, a route for protons to exit the active site cavity is also a requirement of the magnesium chelatase
mechanism and a chain of buried solvent adjacent to E625 could also act as a proton wire, providing a path to bulk solvent for
protons abstracted from the substrate prior to magnesium insertion.
Conclusion
The entire biosynthetic pathway for chlorophyll has been heterologously expressed in E. coli37 and while we now know all the
enzymes required to make this globally crucial pigment, we still lack a detailed mechanistic understanding of the individual
reactions. The initiation and regulation of the chlorophyll pathway are important, and MgCH plays a pivotal role in both
processes. Moreover, the chemistry of the MgCH catalyzed insertion of the Mg2+ ion into protoporphyrin is a particularly
challenging and energetically demanding reaction. Synthetic routes to Mg-porphyrin products usually require anhydrous and
oxygen-free environments, with high temperatures and long reaction times38, in stark contrast to the constraints that operate in
nature, which require insertion of magnesium into protoporphyrin in aqueous solvent. The enzyme must therefore sequester
porphyrin away from solvent, generating a reaction vessel that can control the location of water molecules in the active site.
Magnesium chelatase is a large multi-subunit complex. The ChlH subunit binds to porphyrin in the absence of ChlID22, 26
and can associate to ChlID, either with or without porphyrin. The binding affinity between ChlD and ChlH is ≈ 330 nM20, a
far weaker interaction than between ChlD and ChlI (Kd ≈ 7 nM19). For a long time the ChlH-PIX complex has been viewed as
a substrate for ChlID39.
Our work has used a combination of X-ray crystallography, in silico modelling of ligand binding and rational mutagenesis
to probe the structure and catalytic function of ChlH. The binding site of the porphyrin substrate has been located, buried
deep within the body domain of ChlH and located close to a catalytically essential glutamate (E660). We have shown from
our structures that the bulk of ChlH is composed of two closely associated sub-domains (Body I and II) connected by a
linking loop. Analysis of B-factors of the mainchain atoms show that Body II has on average much lower B-factors than
Body I (Supplementary Fig. S3). Body II carries all of the substrate binding residues that surround sites 1 and 2 at the base
of the active site cavity, whilst Body I possesses a number of flexible loops that have different conformations across our set
of structures. Moreover, we can induce conformational changes in these loops via mutations (E625K and E660W) without
decreasing substrate binding affinity, suggesting that they are not the main driver for recruiting substrate. We propose therefore
that substrate can be loaded onto Body II with ChlH in a more open conformation, then the active site cavity can close around
the substrate by rearrangement of the loops by induced-fit. Presumably the ChlI-D-MgATP2− complex is recruited to drive
these motions by ATP hydrolysis. The insertion of magnesium into PIX is thermodynamically unfavourable14, but our previous
work shows a considerable mismatch between the ∆G of Mg2+ insertion and the ATP stoichiometry of the reaction14, 19, 40. We
previously suggested that this mismatch could be due to a probabilistic mechanism, where not every hydrolysis of MgATP2−



































Figure 4. A chain of buried solvent features are present adjacent to E660 within the Syn_ChlH structure. a, The four buried
positive difference features are shown as a green mesh (Fo-Fc map contoured at 3 σ ) with a dummy atom (yellow sphere)
modelled at the centre of each feature. Surrounding residues are drawn as sticks and labelled, the interior walls of the active site
cavity (AS) are drawn as a partially transparent pale blue surface and the relative positions of the modelled PIX (green) and
Loop 1 (red) are shown for context. White arrows indicate two paths to bulk solvent, via a channel adjacent to E625 and on the
surface of the protein, above F459 . b, The view in A is rotated 90o and much of the active site cavity is stripped away, showing
a close approach (2.2 Å) between the Y653-OH and one of the buried electron density features, suggesting it might not be a
water molecule. The features are labelled 1-4 in red text, corresponding to the description in the main text. c, Sequence
alignment of ChlH and CobN. TH. H, Thermosynecoccus elongatus; AT. H, Arabidopsis thaliana; OS. H, Oryza sativa subsp.
japonica; ChlH, Synechocystis sp. 6803; SC. H, Synechococcus sp. (strain WH8102); PM. H, Prochlorococcus marinus (strain
MIT 9301); TS. H, Thermosynechococcus sp. NK55a; CobN, Brucella melitensis. d, Time courses of MgCH assays with WT
and E625; assays were performed in triplicate and are displayed as the mean with stand deviations shown in shading. e, Mg2+
dependence of the steady state rate of Mg2+ chelation for WT and Y653T ChlH, lines are theoretical and described by Equation
6, with parameters: WT, kcatMg = 0.38 ± 0.01 µM min-1, S0.5Mg = 3.99 ± 0.12, n = 2.8 ± 0.2 µM; Y653T, kcatMg = 0.16 ±
0.01 µM min-1, S0.5Mg = 4.41 ± 0.38, n = 2.4 ± 0.3 µM. In panel e each data point is an independent experiment. Assays in
panels d and e contained 0.1 µM ChlD, 0.2 µM ChlI, 0.4 µM WT or mutant ChlH in 50 mM MOPS/KOH, 0.3 M glycerol, 1




Figure 5. The E625K and E660W mutations alter the conformation of loops around the active site. a, The WT structure of
Syn_ChlH is shown in teal (Body I), with a grey surface indicating the internal surface surrounding the modelled substrate
(green) and Loop 1 shown in red. The structure of the E625K mutant (beige) is superimposed, with the loop bearing K625
(Loop 2; F618-P640 - becomes disordered in the E625K structure from residue 627) highlighted in yellow. The E625K
mutation dramatically alters the conformation of Loop 2, which obliterates a buried solvent channel that is positioned behind
E660 (indicated by the green mesh and small yellow spheres) (see Fig. 4 and corresponding text for a detailed description).
Although much of the rest of the structure remains unchanged, including the position of E660 and H1174, the movement of
Loop 2 causes the position of Loop 1 (purple) to alter. b, A comparison of the inside surface of the active site between the WT
and E625K structures. The conformational change of Loop 2 alters the shape of the active site cavity in the E625K mutant,
creating more volume adjacent to a buried solvent channel. This presumably alters the molecular environment around E660
(surfaces were generated with Loop 1 coordinates omitted); WT = blue and E625K = beige, cavity edge is indicated by a
dashed line, in blue and black, respectively. c, A view of the active site cavity in the E660W mutant structure (beige), showing
the position of the tryptophan sidechain compared to that of E660 in the WT structure (coloured by domain; Body I teal and
Body II pale blue). All the putative substrate binding residues on Body II have conserved positions in the two structures. For
context, the position of Loop 1 in each structure is also shown (red). d, A broader overview of the region surrounding W660,
showing the conformational change in Loop 1 (red), Loop 2 (yellow) and Loop 3 (green) (Q575-D583), compared to their
conformations in the WT structure (teal). All these loops are on Body I of Syn_ChlH. Body II is shown as a partially cut-away
surface and the E660/H1174 pair is shown as sticks.
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they may be thermodynamically freely accessible, MgATP2− hydrolysis could be required to accelerate progression through
these conformations, accounting for at least some of the large ATP stoichiometry (15 - 40 molecules of ATP hydrolysed per
MgPIX formed).
The related class II enzyme protoporphyrin IX ferrochelatase (PpfC) might provide useful clues to the potential mechanism
for magnesium insertion. Ferrochelatase is the most extensively studied member of the chelatase family and uses an identical
porphyrin substrate, but inserts a ferric ion into PIX. The large number of crystal structures of PpfC determined, including some
with either native or non-native porphyrins bound, coupled with extensive kinetic analyses, has led to a detailed mechanistic
proposal for the enzyme. In PpfC, a distal His abstracts protons from PIX towards a patch of negatively charged residues, while
a Met residue on the opposite face has been proposed to deliver Fe(II) ions to the substrate35, 41, so that enzyme residues on
both faces of the porphyrin are involved in the reaction mechanism. Our kinetic analysis of the structurally similar H1174
in Syn_ChlH indicates that this residue is not catalytically essential and there is also a lack of negatively charged residues
in the vicinity of the H1174. With the H1174 side of the active site not participating in the reaction, we propose a single
sided mechanism for magnesium chelation, via E660, where both protein abstraction and magnesium ion insertion occur in a
sequential manner on the same face of the porphyrin (Fig. 6) with the free energy from MgATP2− hydrolysis used to drive the
conformational changes that to allow the reaction to proceed.
Methods and Materials
Cloning methods
The truncated version of Thermosynechoccus elongatus ChlH was engineered by introducing a new NdeI site into the DNA at
Asp 925 using QuikChange mutagenesis with the primers detailed in Table S2. QuikChange PCR was carried out according to
the manufacturer’s protocol (Agilent, Cheshire, UK), using pET21aThermoH22 as the template. The PCR product was digested
with NdeI, gel purified and ligated with T4 DNA ligase (Promega). The resultant pET21aThermoH925 construct was verified
by sequencing (GATC).
Site directed mutagenesis
Mutants of ChlH were generated using primers listed in Table S3 using the QuikChange method according to the manufacturer’s
protocol.
Protein production and purification
All full-length magnesium chelatase subunits and the T_ChlH_926 truncation were purified essentially as described previously28.
Protein purity was estimated to be >95% as assessed by SDS-page. For gentle denaturation and refolding of the protein to
attempt to remove co-purified ligands from the active site, 4 ml of ChlH was dialysed against 500 ml of 25 mM Tris, 2 M urea,
pH 7.45, overnight at 4 ◦C. On day two, the protein was then refolded by dialysis with 20 mM Tris, 150 mM NaCl, 1 mM DTT,
pH 7.45 and then finally overnight a final dialysis against the same buffer but with 2 mM DTT overnight, all at 4 ◦C. On day
3 the dialysis sample was diluted into 25 mL of buffer with 2 mM DTT freshly added, before concentrating to 250 µM for
crystallisation trials.
Crystallisation and structure determination
The seleno-methionine incorporated construct representing the N-terminal third of Thermosynechoccus elongatus ChlH
(SeMet_T_926) (residues 926 - 1331) (10 mg ml-1) was crystallised by sitting drop vapour diffusion (1 µl drop, 1:2 ratio,
1 ml reservoir) in 20-22 % PEG 6000, 100 mM Tris, 200 mM MgCl2, pH 8 (290 K). Cubic crystals formed after several
days, which were harvested, cryoprotected in their mother liquor with an additional 25 % ethylene glycol, and flash-cooled
by plunging into liquid nitrogen. Data were collected on a single crystal at the selenium edge (λ = 0.97901 Å) on beamline
i24 at the Diamond Light Source. The crystal belonged to the spacegroup P21 with cell dimensions of a=76.48 Å, b=140.6 Å,
c=78.59 Å and β=108.82 ◦. Data were processed with Xia242 using a CC-half resolution cut-off of 1.84 Å. Shelx43 was used to
locate ~30 selenium sites that had an occupancy of >0.5 and to build a poly-alanine starting model. Native crystals grew in
the same conditions as the SeMet derivative in the presence of 10 mM bipyridine and a higher-resolution (1.64 Å) structure
was determined by molecular replacement using the preliminary structure as a starting model. The structure was subjected to
multiple rounds of manual and automated model building in COOT44 and Buccaneer45, respectively. The model was refined
with Refmac546 and validated using Molprobity47 (See Table E1 for data collection and refinement statistics).
The full-length construct of WT ChlH from Synechocystis sp. (ChlH) and a number of mutants (E600D, E660W and
E625K) were crystallised by sitting-drop vapor diffusion (2 µl drop, 1:1 ratio, 1 ml reservoir) in 0.8-1.2 M sodium citrate pH
7.0 and 2 mM dithiothreitol (290 K). Large triangular rod-shaped crystals grew within several days, which were cryoprotected
in Paratone N oil (Hampton Research) and flash-cooled with liquid nitrogen. Data from WT protein crystals were collected
to 2.54 Å resolution and were processed with Xia242. The crystals belonged to the spacegroup H3 with cell dimensions of
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Figure 6. A proposed model for one-face sequential proton abstraction and magnesium ion insertion into PIX by ChlH. From
the top, the apo-ChlH active site is represented as a schematic cartoon, with the flexible Body I domain represented in teal and
Body II in pale blue. The propionate binding region (sites 1 and 2) is in grey. Moving clockwise, (1) PIX binds to ChlH by
induced fit, with flexible loops on Body I packing around the substrate. Propionates on rings C and D bind to sites 1 and 2, and
are denoted by the letters P. (2) Loop 1 (red) closes the active site cavity and protons are abstracted from pyrrole nitrogens via
Body I (green arrow). (3) ChlH is remodelled by ChlID (not shown in diagram) and hydrolysis of MgATP2− drives Mg2+
delivery (yellow arrow) inserted into PIX via a solvent-filled channel that leads from the surface of the protein to the active site,
also via Body I. (4) The active site reverts to an open state, enabling (5) release of the MgPIX product.
13/34
a=b=320 Å, c=105 Å, α=β=90 ◦, γ=120 ◦. An initial model containing two chains in the asymmetric units was determined
directly by refinement in Refmac546 (CCP4i48) using PDB:4ZHJ23 as a starting model. As chain A was much better defined
in the map than chain B, all of the modelling and structural interpretation was carried out using chain A. All the crystals of
the mutant enzymes belonged to the same spacegroup and cell dimensions as the WT protein, so these structures were also
determined directly by refinement. The resolutions of the mutant structures were somewhat lower than the WT (≈ 2.8 Å, but in
all cases difference density indicated the position of the mutated residue. Refinement was carried out in Refmac5 imposing
secondary structure restraints generated by ProSMART49 and latterly, using jelly-body refinement50. Model building was
carried out in COOT44, which was also used for model validation, along with Molprobity47 (See Table E1 for data collection
and refinement statistics). Images were made with PyMOL (V 1.2r1, Schrödinger, LLC). Structures have been deposited in the
Protein Data Bank under accession codes: 6YS9, 6YSG, 6YT0, 6YTN and 6YTJ.
Ligand docking
Protoporphyrin IX (PIX) docking into full-length Synechocystis ChlH was performed using AutoDock Vina25. An idealised
structure of PIX was downloaded from the PDB (PDB ligand code: PP9, extracted from PDB:2HRE) and hydrogens added
using Open Babel (V.2.3.2,51). A general protocol from52 and the AutoDock Vina website was adapted for this experiment.
The full-length structure of ChlH was prepared for docking using AutoDockTools (MGLTools 1.5.6) where a PDBQT file was
generated, and a 20 Å3 grid for docking was located in the cavity surrounding site 1 (centered around residue E660, at position
-29.2, 37.2, -33.6 for x, y and z for our structure).
Magnesium chelatase assays
Assays were performed as described previously14. Briefly assays were performed in 50 mM MOPS/KOH, 0.3 M glycerol, 1
mM DTT, I = 0.1 (KCl) at 34 ◦C with substrate concentrations of 15 mM MgCl2, 5 mM ATP, 8 µM DIX, unless otherwise
stated in figure legends. Assays were initiated by the addition of enzyme to give final concentrations of 0.1 µM ChlD, 0.2 µM
ChlI and 0.4 µM ChlH. Steady state assays of magnesium chelatase followed formation of the product, MgDIX, over a period of
one to two hours. Reaction progress was monitored using a Omega FluoStar microplate reader (BMG LabTech, Aylesbury, UK),
with excitation at 420 ± 5 nm and emission detected at 580 ± 5 nm. Steady state rates (vss) were calculated using software
supplied by the manufacturer (MARS version 2.41). Non-linear regression analysis was performed using Igor Pro (v. 8.04).
Citrate inhibition assay
Using a 1 M stock of sodium citrate (titrated to pH 7.9) standard magnesium chelatase assays were spiked within an increasing
concentration of citrate (1.6 - 200 mM). As citrate is a known chelator of Mg2+53, the amount of MgCl2 added to each reaction
was equal to the concentration of citrate plus 15 mM (e.g. at 200 mM citrate the concentration of MgCl2 was 215 mM). The
apparent inhibition constant was calculated using Equation 7.
Porphyrin binding studies
Experiments were performed using a FluoroMax 3 spectrofluorometer (Jobin Yvon). Tryptophan quenching assays and
calculations of Kd values for the binding of DIX to ChlH were performed essentially as described previously26, but due to the
high concentrations of porphyrin required for weak binding mutants, a linear component was added to the binding equation54 to
take into account the inner filter effect of porphyrin absorbing light at high concentrations.
Fobs = F0 +Fmin ·
[L]T +[E]T +Kd −
√
([L]T +[E]T +Kd)2 −4[L]T[E]T
2[E]T
+M[L]T (1)
Enzyme in excess porphyrin binding studies
To determine the Kd of DIX to ChlH E660W an enzyme in excess approach was used. Experiments were performed using a
FluoroMax 3 spectrofluorometer (Jobin Yvon). 0.05 µM DIX was mixed with increasing concentrations of ChlH WT or E660W
protein in 50 mM MOPS/KOH, 0.3 M glycerol, pH 7.7 at 34 ◦C. DIX was excited at 395 ± 5 nm and emission spectra recorded
between 550 and 750 nm (5 nm bandpass). The intensity of emission at 611 and 672 nm was plotted, and both wavelength sets
were simultaneously globally fit using equation 2 using the Global Fit package within Igor Pro.
Fobs = F0 +Fmin ·
[L]T +[E]T +Kd −
√





Protein (0.1 mg ml−1) was buffer exchanged into 5 mM sodium phosphate buffer, pH 7.4 and spectra were recorded in a cuvette
with a 0.1 cm path length at 25 ◦C using a JASCO-810 spectrometer (JASCO, UK). Spectra were recorded continuously from
250 to 190 nm (50 nm s−1, 1 nm increments, 4 s response, 6 accumulations) and background subtracted before calculation of









Fluorometric detection of enzyme-porphyrin complex
Experiments were performed using a FluoroMax 3 spectrofluorometer. Fluorescence emission spectra were recorded from 520 -
750 nm (10 nm slit width) with excitation at 280 nm (20 nm slit width). Emission was observed through a 500 nm long pass
filter to exclude internally reflected incident light. 1 µM ChlH protein was incubated with 100 nM DIX for 10 minutes at 34 ◦C
in 50 mM MOPS/KOH, 0.3 M glycerol, pH 7.7, prior to spectra being recorded. Experiments were performed in triplicate.
Data analysis
Non-linear regression was performed using Igor Pro 8.04 (Wavemetrics). Kinetic curves were described by one of the















Where vmax is maximal velocity, KM is the Michaelis constant, Ki is the inihibition constant, [S] is substrate concentration,
n is the Hill coefficient. kcat was calculated based on the concentration of ChlH within assays.







Where vcontrol is the steady state rate in the absence of inhibitor, vbkg is the steady state rate at infinite concentration of
inhibitor, which is held at 0 in the fitting and n is the slope factor or Hill coefficient.
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Figure E1. Magnesium chelatase (ChlIDH) catalyses the ATP dependent conversion of protoporphyrin IX (PIX) into




























Wavelength (Å) 0.97951 0.97633 0.98674 0.97626 0.97630 0.97630
Resolution (Å) 65.75-1.84 64.38-1.64 83.78-2.54 54.6-2.85 79.39-2.7 80.11-2.79
(1.89-1.84) (1.68-1.64) (2.74-2.54) (2.90-2.85) (2.77-2.7) (2.86-2.79)
Space Group P21 P21 H3 H3 H3 H3
Unit Cell Dimensions (a, b,






104.97, 90, 90, 120
321.79, 321.97,
104.92, 90, 90, 120
317.55, 317.55,
104.43, 90, 90, 120
320.42, 320.42,
104.88, 90, 90, 120
Total reflectionsc 850868 (38925) 395673 (23118) 1143007 (227759) 547095 (26068) 627443 (47821) 570782 (42763)
Unique reflectionsc 134717 (9251) 172739 (10643) 133090 (27461) 94580(4748) 107741 (7995) 99929 (7451)
Multiplicityc 6.3 (4.2) 2.3 (2.2) 8.6 (8.3) 5.8 (5.5) 5.8 (6.0) 5.7 (5.7)
Completenessc (%) 99.2 (92.5) 91.2 (76.3) 100 (100) 100 (100) 99.9 (100) 100 (100)
Mean I/σ c (I) 11.9 (1.6) 7.4 (1.6) 12.1 (1.7) 9.4 (1.5) 10.2 (1.3) 6.4 (1.2)
Rpimb,c 0.040 (0.498) 0.057 (0.442) 0.041 (0.495) 0.061 (0.544) 0.059 (0.676) 0.074 (0.659)
CC-half 0.998 (0.482) 0.994 (0.487) 0.999 (0.638) 0.995 (0.560) 0.997 (0.490) 0.993 (0.583)
Anomalous slope 0.923
Anomalous multiplicity 3.1 (2.2)
Anomalous completeness 95.2 (80)
Refinement
Rfactor 0.20 0.20 0.21 0.19 0.21
Rfree 0.25 0.25 0.26 0.23 0.27
RMSD bonds (Å) 0.0078 0.0072 0.0075 0.0041 0.0051
RMSD angles (◦) 1.55 1.55 1.60 1.29 1.38
No. of non-H atoms
Protein 12024 19588 19321 19763 19393
Ligands 4 13 0 0 0
Water 553 114 32 8 19
Average B factors
Main chain 22.3 61.4 63.3 74.0 59.3
Side chains 31.6 68.1 66.2 76.9 74.2
Ligands 28.8 93.4 - - -
Water 23.7 38.9 30.9 47.2 43.2
Ramachandran
favored/allowed (%) 96.7/3.2 93.9/5.6 93.4/6.0 94.7/4.8 92.7/6.7



















Table E1. a Rmerge = ΣhklΣi | Ii − Im| / ΣhklΣiIi. b Rpim = Σhkl
√
1/n-1Σi=1 | Ii − Im| / ΣhklΣiIi, where Ii and Im are the observed intensity and mean intensity of related





Protein Binding site kcat
DIX / min-1 KM
DIX / µM nDIX kcat/KM
DIX / min-1 µM-1 Kd
DIX / µM
WT N/A 0.56 ± 0.01 1.80 ± 0.13 0.31 ± 0.02 0.65 ± 0.38
T987A† 1 0.39 ± 0.01 1.63 ± 0.12 1.9 ± 0.2 0.24 ± 0.02 2.21 ± 0.46
D988A 1 0.27 ± 0.01 3.49 ± 0.43 0.08 ± 0.01 6.32 ± 1.76
S1039A† 1 0.44 ± 0.05 6.80 ± 1.19 1.7 ± 0.2 0.06 ± 0.01 5.91 ± 4.21
V1041A† 1 0.41 ± 0.02 2.63 ± 0.24 1.7 ± 0.2 0.16 ± 0.02 2.32 ± 1.29
R667A/K/E CobN n.d. n.d. n.d. 9.26 ± 5.18
K991A * CobN 0.23 ± 0.03 11.92 ± 2.91 0.02 ± 0.01 4.53 ± 2.15
S1103A 2 0.24 ± 0.01 1.18 ± 0.15 0.20 ± 0.03 1.45 ± 0.49
K1129A 2 0.18 ± 0.02 4.00 ± 0.96 0.04 ± 0.01 10.5 ± 5.4
D1177A▽ 2 0.37 ± 0.02 0.48 ± 0.10 0.77 ± 0.17 0.91 ± 0.23
S1178A 2 0.17 ± 0.01 0.8 ± 0.10 0.21 ± 0.02 0.23 ± 0.20
Table E2. Fit coefficients for mutations in the active site of the ChlH protein with respect to [DIX]. Data from Fig. 3 panels d
and e is described by equation 5 unless stated otherwise, errors reported as ± one standard deviation of the fit coefficient. n.d.
no activity detected. * these residues are adjacent to site 1. † Fitted to the Hill equation (6), where s0.5 is reported instead of KM,





DIX Mg2+ DIX / µM Mg2+ / mM DIX / µM−1min−1 Mg2+ / mM−1min−1 Mg2+
WT 0.45±0.01 0.45± 0.03 1.42±0.12 2.32±0.21 0.32±0.03 0.19±0.02 1.7±0.3
H1174V 0.42±0.01 0.42±0.06 1.52±0.17 2.76±0.68 0.28±0.03 0.15±0.04 1.4± 0.3
E660D 0.11±0.007 0.065±0.005 14.49±1.97 1.47±0.18 0.008±0.040 0.044±0.006 1.6±0.5
Table E3. Characteristic steady state parameters of WT ChlH, H1174V and E660D proteins. Data from Fig. E2. When
magnesium is the varied substrate, data is fitted to Equation 6: * S0.5, † kcat / S0.5. Values reported are the errors reported as ±






















































































Figure E2. a and c, DIX and b and d, Mg2+ dependence of the steady state rate of Mg2+ chelation for WT ChlH (closed
circles), H1174V (open circles), E660D (open squares). Assays contained 0.1 µM ChlD, 0.2 µM ChlI, 0.4 µM WT ChlH or
H1174V in 50 mM MOPS/KOH, 0.3 M glycerol, 1 mM DTT, 10 mM free Mg2+, 5 mm MgATP2- unless stated otherwise.
Lines are theoretical, where steady state rates (vss) were fitted to the Michaelis-Menten equation (Equation 5) in panel a and c








Figure E3. Energy transfer from tryptophans to porphyrin in the active site. a, The structure of ChlH represented as black
ribbon with all native tryptophan residues represented as black spheres. The control mutation, E263, is shown as cyan spheres,
as is the active site E660, with PIX docked in the active site represented as green spheres. b, Fluorescence emission of DIX after
excitation or tryptophans at 280 nM. Black, WT ChlH; blue, E263W, Red, E660W. Averages of three independent biological
repeats are represented with a central solid line and shading representing standard deviation. The peak areas in the insert are the
total integrated number of counts for the full wavelength range shown in the graph. The bars represent the mean value from





Table S1. Summary of all mutants produced in this work for kinetic analysis. When magnesium is the varied substrate, data is fitted to Equation 6: * S0.5, † kcat / S0.5.
n.d. not determined, – no chelatase activity observed. ⋆ these residues are adjacent to site 1. ‡ Fitted to the Hill equation (6), where s0.5 is reported instead of KM, and
kcat/s0.5 instead of kcat/KM. ▽ Fitted to the substrate inhibition equation (7), where Ki = 37.1 ± 7.7 µM. All numerical values are the reported fit coefficients from
non-linear regression analysis, with errors reported as ± one standard deviation.
Protein Area Binding Site Active kcat / min
-1
KM* kcat/KM† n KDIXd Figure Ref
DIX Mg2+ DIX / µM Mg2+ / mM DIX / µM−1min−1 Mg2+ / mM−1min−1 DIX Mg2+
WT 0.45 ± 0.01 0.45 ± 0.03 1.42 ± 0.12 2.23 ± 0.21 0.32 ± 0.03 0.19 ± 0.02 1.7 ± 0.3 0.65 ± 0.38 3,E2,S4
T987A‡ Central Cavity 1 Y 0.39 ± 0.01 n.d. 1.63 ± 0.12 n.d. 0.24 ± 0.02 n.d. 1.9 ± 0.2 n.d. 2.21 ± 0.46 3,S4
D988A Central Cavity 1 Y 0.27 ± 0.01 n.d. 3.49 ± 0.43 n.d. 0.08 ± 0.01 n.d. n.d. 6.32 ± 1.76 3,S4
S1039A‡ Central Cavity 1 Y 0.44 ± 0.05 n.d. 6.80 ± 1.19 n.d. 0.06 ± 0.01 n.d. 1.7 ± 0.2 n.d. 5.91 ± 4.21 3,S4
V1041A‡ Central Cavity 1 Y 0.41 ± 0.02 n.d. 2.63 ± 0.24 n.d. 0.16 ± 0.02 n.d. 1.7 ± 0.2 n.d. 2.32 ± 1.29 3,S4
R667A/K/E Surface Exposed CobN N – – – – – – – – 9.26 ± 5.18 3,S4
K991A⋆ Central Cavity CobN Y 0.23 ± 0.03 n.d. 11.92 ± 2.91 n.d. 0.02 ± 0.01 n.d. n.d. 4.53 ± 2.15 3,S4
S1103A Central Cavity 2 Y 0.24 ± 0.01 n.d. 1.18 ± 0.15 n.d. 0.20 ± 0.03 n.d. n.d. 1.45 ± 0.49 3,S4
K1129A Central Cavity 2 Y 0.18 ± 0.02 n.d. 4.00 ± 0.96 n.d. 0.04 ± 0.01 n.d. n.d. 10.5 + 5.4 3,S4
D1177A▽ Central Cavity 2 Y 0.37 ± 0.02 n.d. 0.48 ± 0.10 n.d. 0.77 ± 0.17 n.d. n.d. 0.91 ± 0.23 3,S4
S1178A Central Cavity 2 Y 0.17 ± 0.01 n.d. 0.80 ± 0.10 n.d. 0.21 ± 0.02 n.d. n.d. 0.23 ± 0.20 3,S4
H1174V Catalytic site Y 0.42 ± 0.01 0.42 ± 0.06 1.52 ± 0.17 2.76 ± 0.68 0.28 ± 0.03 0.15 ± 0.04 1.4 ± 0.3 0.77 ± 0.49 E2,S6
E660D Catalytic site Y 0.11 ± 0.007 0.065 ± 0.005 14.49 ± 1.97 1.47 ± 0.18 0.008 ± 0.040 0.044 ± 0.006 1.6 ± 0.5 3.05 ± 0.53 E2,S6
E660W Catalytic site N – – – – – – – – 0.30 ± 0.01 E3,S7
E660R/H/Q Catalytic site N – – – – – – – – n.d. S8
E625D Buried Channel N – – – – – – – – 0.91 ± 0.40 4,S10
E625K/H/Q Buried Channel N – – – – – – – – n.d. 4







Figure S1. Relationship between the two sub-domains within the body of Syn_ChlH and variation in surface charge inside
the active site cavity. a, Perpendicular views of the two sub-domains of the body of Syn_ChlH are shown with a solid surface
and coloured according to the C-terminal portion (Body II; pale blue), which is equivalent to T_ChlH_926, and the N-terminal
portion (Body I; teal), which forms a C-shaped domain. The head and neck domains are coloured green and yellow,
respectively and are shown as cartoons. Loop 1 is coloured red, indicating the position of the active site cavity, buried between
the two domains. b, An open book view of the electrostatics of the inside surface of the active site cavity (red=negative,
white=neutral, blue=positive). The four mainchain amides sat at the base of the pocket are labelled 1-4 ((1=T987, 2=G986,
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Figure S2. Magnesium chelatase is inhibited by citrate. A standard magnesium chelatase assay was spiked with citrate (from
200 - 1.6 mM) and the steady state rate plotted against citrate concentration, displaying inhibition behaviour, with a calculated
Ki,app of 80 mM. Assays contained 0.1 µM ChlD, 0.2 µM ChlI, 0.4 µM WT or mutant ChlH in 50 mM MOPS/KOH, 0.3 M
glycerol, 1 mM DTT, 10 mM free Mg2+, 8 µM DIX 5 mm MgATP2-, pH 7.7. As citrate binds to magnesium ions in solution53,
the assays contained an excess of 10 mM MgCl2 over citrate to ensure there were free magnesium ions present in solution for




Figure S3. B-factor putty representations of WT and mutant Syn_ChlH subunits showing flexibility in the region of the Body
I domain adjacent to the active site. a, The WT structure of Syn_ChlH is drawn as B-factor putty from low B-factors (blue/thin
tubes) to higher B-factors (red/fat tubes). A partially transparent surface showing each of the domains of the protein is overlaid,
focusing on the two body domains (Body I in teal and Body II in pale blue). B-factors are generally lower in the Body II
domain, showing the protein backbone is more rigid. In the region of Body I adjacent to the active site (*), where the Loops 1-3
are, the B-factors are on average higher, showing this region is more flexible. Parts b-d show the E660D, E625K and E660W
mutants, respectively. In all structures, residues in the head and neck (H/N) domains have the highest overall B-factors.
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Figure S4. Binding studies of DIX to ChlH mutants. Dissociation constants (Kd) of DIX binding to ChlH WT and mutants
were determined by monitoring tryptophan fluorescence quenching. Experiments were performed in assay buffer 50 mM
MOPS/KOH, 0.3 M glycerol, 1 mM DTT, pH 7.7 at 34 ◦C. a - k, Binding isotherms for WT, CobN mutants, site 1 and site 2
mutants. Kds are reported next to each protein, and in table Table E2. Error bars indicate the standard deviation from the mean
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Figure S5. Sequence alignment of ChlH and CobN proteins. TH. H, Thermosynecoccus elongatus; AT. H, Arabidopsis thaliana; OS. H, Oryza sativa subsp. japonica;
ChlH, Synechocysistis sp. 6803; SC. H, Synechococcus sp. (strain WH8102); PM. H, Prochlorococcus marinus (strain MIT 9301); TS. H, Thermosynechococcus sp.
NK55a; CobN, Brucella melitensis. Residues investigated in this study: 1, E625; 2, Y653; 3, E660; 4, R667; 5, T987; 6, K991; 7, S1039; 8, V1041; 9, S1103; 10, K1129;














































Figure S6. Binding of DIX to ChlH H1174V and E660D. a, ChlH H1174V has a similar Kd for DIX as WT protein, Kd= 0.77
± 0.49 µM, where as b, E660D has a Kd = 3.05 ± 0.53 µM. Error bars indicate the standard deviation from the mean of three
independent titrations.
Table S2. Primers used for subcloning Thermosynechoccus elongatus T_926 truncation
Protein Mutation/Cut site Primer forward Primer reverse





































































































Figure S7. Binding and activity data of the ChlH E660W mutant. a Dissociation constant (Kd) of DIX to E660W was
determined by monitoring DIX fluorescence quenching with increasing concentration of protein (see insert). Fluorescent
intensity at 611 nm (open markers) and 672 nm (closed markers) are plotted, Kd = 0.30 ± 0.01 µM. This ’enzyme in excess’
method of determining Kd for DIX was internally consistent with a ChlH WT titration, panel b, Kd = 0.66 ± 0.12 µM (compare
with Kd of 0.66 µM see Fig. S4 panel A). In panels a and b, data are presented as the mean of 3 repeats ± 1 standard deviation.
c Magnesium chelatase activity of WT (black line) protein compared with E660W (green line) where no activity for the E600W
protein is observed. Assays contained 0.1 µM ChlD, 0.2 µM ChlI, 0.4 µM WT or mutant ChlH in 50 mM MOPS/KOH, 0.3 M
glycerol, 1 mM DTT, 10 mM free Mg2+, 8 µM DIX, 5 mm MgATP2-, pH 7.7. For line graphs, the solid lines indicate the









































Figure S8. Activity of ChlH E660 mutants and sequence alignments highlighting conserved E660 and H1174 residues. a,
Time courses of MgCH assays with WT, E625 and E660 mutants of ChlH; assays were performed in triplicate and are
displayed as the mean with standard deviations shown in shading. Assays contained 0.1 µM ChlD, 0.2 µM ChlI, 0.4 µM WT
or mutant ChlH in 50 mM MOPS/KOH, 0.3 M glycerol, 1 mM DTT, 10 mM free Mg2+, 8 µM DIX, 5 mm MgATP2-, pH 7.7. b,
Sequence alignment of ChlH and CobN highlighting conserved Glutamic Acid 660 and Histidine 1174 in Synechocysistis. TH.
H, Thermosynecoccus elongatus; AT. H, Arabidopsis thaliana; OS. H, Oryza sativa subsp. japonica; ChlH, Synechocysistis sp.
6803; SC. H, Synechococcus sp. (strain WH8102); PM. H, Prochlorococcus marinus (strain MIT 9301); TS. H,
Thermosynechococcus sp. NK55a; CobN, Brucella melitensis
Figure S9. CD spectra of E625 mutants. E625 mutations do not have have gross changes in secondary structure. CD spectra











































Figure S10. DIX binding studies of ChlH E625D and Y653T mutants. Both E625D and Y653T mutations are able to bind
DIX to a similar degree as WT. a, E625D Kd=0.91±0.40 µM; b, Y653T, Kd=2.15±1.40 µM. Error bars indicate the standard
deviation from the mean of three independent titrations
Table S3. Primers used for site directed mutagensis
Protein Mutation Primer forward Primer reverse
ChlH E625Q CTGTTTACCGGGCATAAACTGCAAAGAACCGTGGGTGCC GGCACCCACGGTTCTTTGCAGTTTATGCCCGGTAAACAG
ChlH E625D TGTTTACCGGGCATAAAATCCAAAGAACCGTGGGT ACCCACGGTTCTTTGGATTTTATGCCCGGTAAACA
ChlH E625H CTGTTTACCGGGCATAAAATGCAAAGAACCGTGGGTGCC GGCACCCACGGTTCTTTGCATTTTATGCCCGGTAAACAG
ChlH E625K GCACCCACGGTTCTTTGAAATTTATGCCCGGTAAA TTTACCGGGCATAAATTTCAAAGAACCGTGGGTGC
ChlH Y653F CCATTCCCAACTTGTACTACTTCGCCGCCAACA TGTTGGCGGCGAAGTAGTACAAGTTGGGAATGG
ChlH S659A ATGGTAGCTTCAGCAGGATTGTTGGCGGC CCGCCAACAATCCTGCTGAAGCTACCATCG
ChlH E660A AACAATCCTTCTGCAGCTACCATCGCCAAACG TTTGGCGATGGTAGCTGCAGAAGGATTGTTGG
ChlH E660W AACAATCCTTCTTGGGCTACCATCGCCAAACG TTTGGCGATGGTAGCCCAAGAAGGATTGTTGG
ChlH E660D AACAATCCTTCTGATGCTACCATCGCCAAACG TTTGGCGATGGTAGCTCGAGAAGGATTGTTGG
ChlH E660H AACAATCCTTCTCATGCTACCATCGCCAAACG TTTGGCGATGGTAGCATGAGAAGGATTGTTGG
ChlH E660Q AACAATCCTTCTCAAGCTACCATCGCCAAACG TTTGGCGATGGTAGCTTGAGAAGGATTGTTGG
ChlH E660R AACAATCCTTCTCGAGCTACCATCGCCAAACG TTTGGCGATGGTAGCATCAGAAGGATTGTTGG
ChlH R667A TGGACGCATAACCCGCCCGTTTGGCGATGG CCATCGCCAAACGGGCGGGTTATGCGTCCA
ChlH R667K GGTGGACGCATAACCCTTCCGTTTGGCGATGGTA TACCATCGCCAAACGGAAGGGTTATGCGTCCACC
ChlH R667E GTGGACGCATAACCCTCCCGTTTGGCGATGGT ACCATCGCCAAACGGGAGGGTTATGCGTCCAC
ChlH D988K TCTGTGCTCTGGGGTACGAAGAACATCAAAACCTACGGC GCCGTAGGTTTTGATGTTCTTCGTACCCCAGAGCACAGA
ChlH T987A TTCTGTGCTCTGGGGTGCGGATAACATCAAAACC TAGGTTTTGATGTTATCCGCACCCCAGAGCACAGAAGC
ChlH D988A TTCTGTGCTCTGGGGTACGGCTAACATCAAAACC TTTTGATGTTAGCCGTACCCCAGAGCACAGAAGC
ChlH K991A TACGGATAACATCGCAACCTACGGCGAATCC ATTCGCCGTAGGTTGCGATGTTATCCGTACC
ChlH S1039A TGGTGGTGAATTGTGCCGGGGTATTCC ATCCCGGAATACCCCGGCACAATTCACCACC
ChlH S1041A TGGGGTCGGAGGCGAAGTAGTGGG ATCCCGGAATACCCCGGCACAATTCACCACC
ChlH S1103A TTGACGTTGGAAGCATAGGAACCGGAGGCG AATTGTTCCGGGGCATTCCGGGATCTG
ChlH K1129A TTGAAAGCGAAGGACGCGCGTTTGAGGTACATTTCC ATGTACCTCAAACGCGCGTCCTTCGCTTTCAACTCC
ChlH S1178A TTGGTGGGGTCGGCGTCGAAGTAGTGG CACTACTTCGACGCCGACCCCACCAAG
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